Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPSACOX study of capsaicin 8% patch for chronic coccygodynia
2023-504644-34-00Phase 3Authorised
- Sponsor
- CHU de Nantes
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coccydynia comparing Capsaicin 8% patch with Placebo patch (2 arms). Planned start Nov 2023; status: authorised.
02
Drugs
capsaicin
03
Conditions
coccydynia
Beyond the preview
Go deeper on 2023-504644-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504644-34-00.